×
0 - items
  • Products
    • ClearYield Isolation (DNA/RNA)
    • LinkLyse™ Homogenizers
    • PCR and qPCR
      • PCR and qPCR Reagents
      • AMPlify™ PCR and qPCR Consumables
      • Thermal Cyclers and qPCR Systems
      • AMPlify™ PCR/qPCR Sealing Film
    • Electrophoresis Reagents and Stains
    • Electrophoresis Instruments and Tanks
    • Imaging and Illumination
    • Lab Consumables
      • Tubes
      • Tube Racks and Storage
      • Cell Strainers
      • Blot Boxes
      • General Consumables
    • Cell Culture Reagents/FBS
    • Transfection Reagents
      • Life Science Research
      • Bioproduction
    • Liquid Handling
    • Cooling and Cold Storage
    • Benchtop Equipment
      • Mixers and Shakers
        • Mixers and Vortexers
        • Rockers
        • Rotators and Rollers
        • Orbital Shakers
      • Centrifuges
        • Microcentrifuges
        • Compact Centrifuges
        • Hermle Centrifuges
      • Incubators and Baths
      • Shaking Incubators
      • Hotplates and Stirrers
      • Laboratory Balances
      • Sterilization
  • Specials
  • About us
  • Contact Us
  • My account
    ×
    0 - items
Home / Transfection Reagents / Life Science Research / in vivo-jetRNA® mRNA transfection reagent for animal injections

in vivo-jetRNA® mRNA transfection reagent for animal injections

      • Adaptable: Suited for any injection route to target any organ
      • Safe: Maintain healthy animals and organs
      • Time-saving: Ready-to-use reagent with an easy protocol
      • Tailored: Customized protocols from in vivo delivery experts

     

$9,999.00

20-101000013   $9,999.00
20-101000021   $9,999.00
SKU: 20-204 Series

Category: Life Science Research
  • Description
  • Additional information
  • specifications
  • Reviews (0)

Description

Adaptable: target your organ of choice via different administration routes in various animal models, including mice

in vivo-jetRNA® is the reagent of choice to deliver mRNA to various organs using different administration routes (Fig.1). This is attributable to its intrinsic properties: in vivo-jetRNA® protects its payload against ubiquitous endonucleases, prevent non-specific interactions with proteins and promote efficient cell entry.

Choice of the administration route leads to different mRNA biodistribution. in vivo-jetRNA®-mediated mRNA delivery leads to gene expression in numerous organs, through intraperitoneal injection, especially in the spleen and nodes that have a major role in the immune response but also in other organs such as liver, pancreas and uterus (Fig. 2).

Being a non-viral delivery reagent, in vivo-jetRNA® can be safely administered in animals. By avoiding conventional vaccine approaches, it allows to generate a new class of vaccines that rely on direct gene transfer. This concept has several advantages – it is safer for the recipients, faster and cheaper to produce compared to viral vector vaccines or peptide loaded APC (Antigen Presenting Cells), and it has an immense potential to tackle many unmet medical needs.

Fig. 1: Biodistribution of mRNA/in vivo–jetRNA® complexes via different administration routes in mice. Complexes were formed using the recommended conditions with mRNA/in vivo-jetRNA® and were injected via intramuscular, intravenous or intraperitoneal  administration routes in mice. Fluorescence signals were observed with Bioluminescence imaging using IVISsystem (PerkinElmer) for both Cy7 (on the left) and Luciferase (on the right).

<em>in vivo</em>-jetRNA - distribution organs

Fig. 2: Distribution of mRNA delivered by in vivo-jetRNA® in mice through intraperitoneal injection. Complexes were formed using the recommended conditions with luciferase mRNA/in vivo-jetRNA® and were injected via intraperitoneal (IP) administration routes in mice. 24 hours after injection, different organs were extracted and luciferase expression was measured.

 

Safe: mRNA vaccines without any sign of toxicity

in vivo-jetRNA® is the best choice in terms of safety. There are no secondary effects after injection, all animals remain healthy and no animal pain has been encountered. After administration of mRNA – in vivo-jetRNA® complexes by any administration route, targeted organ remains phenotypically intact and no tissue damage is observed.

 

Time saving with a ready-to-use solution

in vivo-jetRNA® comes with a simple and straightforward protocol. in vivo-jetRNA®/mRNA complex solution is prepared in two steps and ready to be injected to the animal in 15 minutes: a gain of time with minimal effort (Fig. 4).

<em>in vivo</em>-jetRNA - protocol

Fig. 4: in vivo-jetRNA® protocol. This two-step protocol is suitable with direct injection of in vivo-jetRNA®/mRNA complexes through any systemic or local administration route.

Weight 6 lbs
Dimensions 10 × 9 × 8 in

specifications

Brand:

PolyPlus-transfectionⓇ

Reagent:

in vivo-jetRNA® transfection reagent

Molecule Delivered:

mRNA

Target Organs:

All organs (depending on the injection route)

Number of Injections in mice / 1mL:

+50 intravenous injections or 100 intramuscular injections

Injection Routes:

Various administration routes (systemic or local)

Applications:

Vaccination / immunization

Cancer Therapy

in vivo functional studies (Gene expression, CRISPR genome editing)

Storage:

5°C (+/-3°C)

Provided With:

mRNA buffer

Reviews

There are no reviews yet.

Be the first to review “in vivo-jetRNA® mRNA transfection reagent for animal injections” Cancel reply

Your email address will not be published. Required fields are marked *

Protocols and Supporting Documents

in vivo-jetRNA Flyer

in vivo-jetRNA Protocol

in vivo-jetRNA Poster

related products

jetOPTIMUS® Best in Class Transfection Reagent

    • Highly efficient: reach maximal gene expression in hard-to-transfect cells
    • Cost-effective: use minimum reagent volume and DNA quantity
    • Biologically relevant: keep an excellent cell viability & morphology
    • Time-saving: transfect with an optimized ready-to-use protocol

Starting at $90.00 – $731.00

jetPEI® DNA Transfection Reagent

    • Well-suited for adherent and suspension cells
    • Fast and efficient methods to transfect cells for HTS
    • Compatible with serum and antibiotics
    • Exceptionally reproducible results
    • Reverse, batch & forward protocols available

Starting at $480.00 – $1,685.00

biolink laboratories llc.

Web: www.BioLinkLaboratories.com

Ph: 202.848.3463    EM: info@biolinklab.com